World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
71949
World Ranking
8398
National Ranking
4342

Overview

Steven I. Sherman is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medicine, with notable contributions in the fields of endocrinology, diabetes and metabolism, oncology, pulmonary and respiratory medicine, radiology, nuclear medicine and imaging, and genetics.

The scientist's work covers several main topics, including:

  • Thyroid Cancer Diagnosis and Treatment
  • BRCA gene mutations in cancer
  • Lung Cancer Treatments and Mutations
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer-related Molecular Pathways
  • Cancer Genomics and Diagnostics
  • Cancer Diagnosis and Treatment

Steven I. Sherman has contributed research to frequent publication venues such as:

  • Journal of Clinical Oncology
  • Journal of the Endocrine Society
  • Thyroid
  • Annals of Oncology
  • The Journal of Clinical Endocrinology & Metabolism

Among the recent papers linked to their work are:

  • Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial (2021), The Lancet Oncology
  • Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer (2021), Journal of Clinical Oncology
  • Distant Metastases From Childhood Differentiated Thyroid Carcinoma: Clinical Course and Mutational Landscape (2020), The Journal of Clinical Endocrinology & Metabolism
  • Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies (2020), ESMO Open
  • Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial (2022), Cancer

The scientist has collaborated frequently with several co-authors, including Maria E. Cabanillas, Mimi I. Hu, Ramona Dadu, Naifa L. Busaidy, and Mark Zafereo, reflecting a network of ongoing research partnerships in related medical disciplines.

Best Publications

  • 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

    Bryan R. Haugen;Erik K. Alexander;Keith C. Bible;Gerard M. Doherty

  • Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

    David S. Cooper;Gerard M. Doherty;Bryan R. Haugen;Richard T. Kloos

  • Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

    David S. Cooper;Gerard M. Doherty;Bryan R. Haugen;Richard T. Kloos

  • Integrated Genomic Characterization of Papillary Thyroid Carcinoma

    Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally

  • Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement

    Mary C. Frates;Carol B. Benson;J. William Charboneau;Edmund S. Cibas

  • Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

    Martin Schlumberger;Makoto Tahara;Lori J. Wirth;Bruce Robinson

  • Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

    Marcia S Brose;Christopher M Nutting;Barbara Jarzab;Rossella Elisei

  • Cabozantinib in Progressive Medullary Thyroid Cancer

    Rossella Elisei;Martin J. Schlumberger;Stefan P. Müller;Patrick Schöffski

  • A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.

    Ernest L. Mazzaferri;R. J. Robbins;C. A. Spencer;L. E. Braverman

  • Outcomes of patients with differentiated thyroid carcinoma following initial therapy.

    Jacqueline Jonklaas;Nicholas J. Sarlis;Nicholas J. Sarlis;Danielle Litofsky;Kenneth B. Ain

  • A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.

    Bryan R. Haugen;Furio Pacini;Christoph Reiners;Martin Schlumberger

  • Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer

    Maria A Kouvaraki;Suzanne E Shapiro;Bruno D Fornage;Beth S Edeiken-Monro

  • Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.

    F Pacini;F Pacini;Pw Ladenson;M Schlumberger;A Driedger

  • Activity of XL184 (cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer

    Razelle Kurzrock;Steven I. Sherman;Douglas W. Ball;Arlene A. Forastiere

  • Motesanib diphosphate in progressive differentiated thyroid cancer.

    Steven I. Sherman;Lori J. Wirth;Jean Pierre Droz;Michael Hofmann

  • Prospective multicenter study of thyroid carcinoma treatment initial analysis of staging and outcome

    Steven I. Sherman;D M B James Brierley;Matthew Sperling;Kenneth B. Ain

  • Thyrotropin Suppression and Disease Progression in Patients with Differentiated Thyroid Cancer: Results from the National Thyroid Cancer Treatment Cooperative Registry

    David S. Cooper;Bonny Specker;Mona Ho;Matthew Sperling

  • Iodine Biokinetics and Dosimetry in Radioiodine Therapy of Thyroid Cancer: Procedures and Results of a Prospective International Controlled Study of Ablation After rhTSH or Hormone Withdrawal

    Heribert Hänscheid;Michael Lassmann;Markus Luster;Stephen R. Thomas

  • Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer

    Martin J. Schlumberger;Rossella Elisei;Lars Bastholt;Lori J. Wirth

  • Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits

    Daniel J. Drucker;Steven I. Sherman;Fred S. Gorelick;Richard M. Bergenstal

Frequent Co-Authors

Martin Schlumberger
Martin Schlumberger University of Paris-Saclay
Robert F. Gagel
Robert F. Gagel The University of Texas MD Anderson Cancer Center
Rossella Elisei
Rossella Elisei University of Pisa
Douglas B. Evans
Douglas B. Evans Medical College of Wisconsin
Bruce G. Robinson
Bruce G. Robinson University of Sydney
Furio Pacini
Furio Pacini University of Siena
Jeffrey E. Lee
Jeffrey E. Lee The University of Texas MD Anderson Cancer Center
Gilbert J. Cote
Gilbert J. Cote The University of Texas MD Anderson Cancer Center
Gary L. Clayman
Gary L. Clayman The University of Texas MD Anderson Cancer Center
David S. Hong
David S. Hong The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA doesn't always start—and end—with a traditional MD. Many students and professionals explore online degrees that can open doors to a wide range of roles within healthcare. For those interested in healthcare leadership, a cahme accredited online mha programs list highlights top options to earn a Master of Healthcare Administration recognized for its quality and flexibility.

Nursing professionals looking to advance their careers might consider programs designed for working adults. There are convenient online rn to bsn programs without clinicals, which allow you to complete your degree fully online – perfect if you’re balancing a job or family commitments.

For advanced practice nurses seeking the highest level of training, you can find options like a 1 year dnp program online for a fast-track Doctor of Nursing Practice. Additionally, if affordability is a concern, several affordable dnp programs are available to help reduce financial stress while achieving your career goals.

Best Scientists Citing Steven I. Sherman

Trending Scientists

Recently Published Articles